On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayDec 30, 2021 11:53 am

NetworkNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) Expanding Robust Portfolio of Novel Compounds

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company, has aimed to transform the treatment of mental health disorders and addiction since its inception. The company has already developed first- and second-generation novel therapeutics designed to treat addiction, post-traumatic stress disorder (“PTSD”) and other mental health conditions. “Mydecine recently released its third-quarter 2021 update and a noteworthy announcement for the 2021 calendar year. It offers a glimpse into achievements to date, and what stakeholders can anticipate in the last quarter of the 2021 financial year and for the 2022 calendar year,” reads a recent article. “Most notably, Mydecine…

Continue Reading

ThursdayDec 30, 2021 11:43 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Board Approves Share Repurchase Program

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is repurchasing up to 2 million company shares. The company announced that its board of directors had approved the move, which allows the company to purchase the shares over the next year at prevailing market prices. The repurchasing plan, which begins on Jan. 4, 2022, and ends on Dec. 30, 2022 (unless the company ends the program earlier), allows FSD Pharma to use its excess cash reserves to strategically return value to shareholders. The plan calls for…

Continue Reading

ThursdayDec 30, 2021 11:39 am

NetworkNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Core Operations to Center Around Its Rapidly Growing SaaS Platform

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has recently announced that it will no longer have to consolidate the financials of its former subsidiary, BIGtoken Inc. Following the successful spin-off of BIGtoken, SRAX’s core operations will be centered around Sequire, which has grown to over 9 million followers whilst simultaneously seeing its number of subscribers swell to 250 public companies. “Sequire has witnessed the company’s growth trajectory rise from strength to strength, with the company recently announcing the launch of its new IR website builder,…

Continue Reading

ThursdayDec 30, 2021 11:04 am

NetworkNewsBreaks – Why Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Is ‘One to Watch’

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded, vertically integrated plant-based foods company. Eat Well combines the best of agribusiness, food tech and CPG brands to supply the world with innovative, delicious and better-for-you foods. “The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (‘CPG’),” reads a recent article. “Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts…

Continue Reading

ThursdayDec 30, 2021 10:35 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Tribe Public’s Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, today announced that its CEO Eric A. Adams, SVP and General Manager of BayMedica, Shane Johnson, and VP of Commercial Operations Chris Meiering will present at Tribe Public’s upcoming webinar presentation and Q&A event. The event, titled “Addressing the Increasing Demand for Rare Cannabinoids,” is slated to begin at 8 a.m. Pacific/11.a.m. Eastern on Jan. 6, 2022. Interested parties should visit https://nnw.fm/2DndY to register to join the complimentary, ZOOM webinar-based event. Once registered, participants may begin forwarding their questions for InMed and BayMedica’s management to…

Continue Reading

ThursdayDec 30, 2021 10:02 am

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Settles Debt, Completes Refinance, Grants Stock and Options

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has issued 6,784,812 shares to settle a CAD$5.1 million (US$4.0 million) debt. By settling the debt at a favorable conversion price (approximately CAD$0.75 or US $0.56 per share), RWB will realize an accounting gain of approximately CAD$2.3 million (US$1.8 million). Further to its April 28 press release, RWB has refinanced the CAD$12.8 million (U.S.$10 million) principal amount of its “Seven month” vendor take-back note issued to High Street Capital Partners LLC, in connection with RWB Florida LLC’s acquisition of all of the…

Continue Reading

ThursdayDec 30, 2021 9:58 am

NetworkNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Unveils New Division Focused on ESG; Announces Investment in MADA Analytics

DigiMax Global (CSE: DIGI) (OTC: DBKSF) has entered the Environmental, Social and Governance (“ESG”) sector. The company made this strategic move by launching an ESG Solutions Division that will use artificial intelligence (“AI”) and predictive analytics to enable investors to make better investment decisions and assist developers in lowering their cost of capital. The company anticipates immediately aiding green-energy development and operations as they track and predict carbon credit arbitrage and trading opportunities around the globe. DIGI may also offer large investors assistance in monitoring and evaluating ESG opportunities and trends. One of DigiMax’s initial steps in this new space is…

Continue Reading

WednesdayDec 29, 2021 2:38 pm

NetworkNewsBreaks – Titan International, Inc. (NYSE: TWI) Featured in Research Note from Sidoti

Price Target Raised; Estimates Raised Titan International, Inc. (NYSE: TWI) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Raise Price Target To $15 (From $13), As We Lift Our 2021-2023 EPS Estimates On Rallying Crop Prices, The Industry’s Healthy Order Book And The Chairman’s Positive Outlook.” Click here to access the full report. About Titan International, Inc. Titan International is a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products. Headquartered in Illinois, the company globally produces a broad range of products to meet the specifications of original…

Continue Reading

WednesdayDec 29, 2021 12:50 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Approval from Independent Review Board for DehydraTECH-CBD Human Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has received Independent Review Board ("IRB") approval for its planned DehydraTECH-CBD human hypertension study HYPER-H21-4; the approval was received earlier than anticipated. The study is designed to "de-risk" outcomes prior to the company’s planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease. The six-week study, which is entirely funded through the existing cash resources, is planned to include 60 volunteers, aged 45 to 70, using three 150 mg doses of DehydraTECH-CBD daily for the duration of the study. Dosing…

Continue Reading

WednesdayDec 29, 2021 12:18 pm

NetworkNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Solutions to Empower People to Take Charge of Their Health, Well-Being

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. Since its founding in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved to create wearable technologies and digital health care solutions that encourage and empower people to take charge of their health and well-being. “The company’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible continuous glucose monitor (‘CGM’) designed to help people with diabetes and prediabetes manage…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217